). An expression plasmid containing both an U6 promoterdriven sgRNA and a CBh promoter-driven SpCas9-2A-GFP was used to target the RASGAP domain. (B) TPO2 organoids in selection medium that have been transfected with indicated sgRNAs and Cas9. White arrow heads indicate representative background organoids. Yellow arrows indicate successful organoids that are significantly larger than background. Bar graph depicts the relative number of organoids with a size larger than background organoids as determined in the negative control. Area of alive RASGAP knock out organoids was measured using calcein green assay (see Materials and Methods). (B, D) Genetic strategy for CRISPR/Cas9-mediated generation of small indels in exon 1 and 3 of RASA1 respectively via non-homologous end-joining. The black boxes illustrate exon 1 and 3 respectively, and thin strokes illustrate introns. Scissors show double stranded breaks generated by different sgRNAs. Blue arrows illustrate PCR primer pairs. The agarose electrophoresis gel shows the PCR product of the targeted exons of RASA1 in selected clones. PCR amplification products were sequenced. Regions of sgRNAs complementary to the protospacer (underlined) are shown in red. Red arrow heads indicate cleavage sites and introduced mutations are shown in orange Note that the RASA1 exon 3 sequence of clone 14 reveals to be wild type. (C, E) Western blot analysis of RASA1 levels in the indicated organoid lines. Note that targeting of exon 1 of RASA1 results in predominant expression of a truncated isoform due to an alternative start site in exon 1. Asterisks indicate wild type RASA1 protein presence. In agreement with the wild type sequence of clone 14, normal levels of RASA1 is detected. (F) Representative picture of RASA1 exon 3 knock out organoids selected by EGF depletion and EGFR inhibition (afatinib).
Supplementary Figure 5:
Genomic integration of puromycin selection cassette in NF1 and RASA1 knock out patientderived CRC organoids. (A) The structure of the targeted exon of NF1 is depicted at the top. Black box illustrates exon 1, and thin strokes illustrate introns. Blue arrows illustrate PCR primer pairs. The agarose electrophoresis gel shows the ~300 bp PCR product of the integrated puromycin selection cassette at the targeted NF1 locus in the selected clones (knock out clones # 6 and 12). (B) The structure of the targeted exon of NF1 and RASA1 is depicted at the top. The agarose electrophoresis gel shows the ~1 kb PCR product of the integrated puromycin selection cassette in the genome of the selected clones that were targeted for homologous recombination (RASA1 knock out clones # 1, 3, 5 and 10, and NF1 knock out clones # 6, 8, 12 and 14) . The donor template (DT) was used as a positive control. (C) Uncropped images of western blot analysis for NF1 and RASA1 presence in the indicated organoid lines.
